Purdue Pharma on Monday announced the launch of Hysingla ER (hydrocodone bitartrate) extended-release tablets CII. According to the company, the once-daily drug is the first and only hydocodone product to be recognized by the Food and Drug Administration as having properties that deter misuse and abuse via chewing, snorting and injection.
The Independence Blue Cross Center for Health Care Innovation has invested $2.4 million in the Conshohocken, Pa.-based start-up.
Eisai on Tuesday announced the launch of a new savings card for Belviq (lorcaserin HCl) CIV, the most-prescribed branded FDA-approved prescription drug therapy for chronic weight management.
The Food and Drug Administration on Wednesday announced approval for Cosentyx (secukinumab), indicated for the treatment of adults with moderate to severe plaque psoriasis.
If its goal of expanding health coverage to more Americans is fully realized, the Affordable Care Act could end up pulling as many as 30 million more people into the ranks of the newly insured. That means rising prescription counts and more patients at pharmacy counters and in drug store aisles, but it also poses challenges in managing and educating patients about their benefits.
Doctors making house calls? It sounds so …19th century, conjuring up images of a tweedy medical practitioner arriving on someone’s doorstep by horse and buggy with a medical bag and a stethoscope.
Call it the point-of-care revolution: The accelerating shift of patients from overcrowded doctors’ offices to accessible, clinically engaged pharmacists and retail clinicians for front-line health-and-wellness services.
Will patient screenings and advanced, gene-based diagnostics become a standard and universally accepted part of community pharmacy’s service platform?
With specialty and biotech drugs claiming an ever-greater share of the pharmaceutical market and spawning a backlash from payers and patients over their high price tags, pharmacy operators are smack in the middle of a growing tug of war between the drug industry, the public and private health plans struggling to keep up with the new drug-cost paradigm.
With the development and use of innovative wearable health devices and smartphone health apps exploding, the decentralization of health care will likely reach a crescendo in 2015. Increasingly, consumers and physicians are embracing technologies that can continuously monitor a host of such physical conditions as heartbeat, lipid levels, medication adherence or motion — and wirelessly transmit the data to a host computer or smartphone.